Product Details
Non-carrier added Lutetium-177 (n.c.a. Lu-177) is emerging as a radioisotope of choice for targeted radionuclide therapy.
This radioisotope is currently being supplied for a range of clinical trials in Australia.
Watch our video to find out more.
Review full product information detailed in the product brochure below.
Ordering details
| Product code | Sizes | Calibration 09:00AM (Sydney, Australia) |
|---|---|---|
|
10870 (ANSTO) 10820 (Imported) |
Min 5Gbq - Max 50Gbq | Tuesday, Wednesday, Thursday and Friday |
View order cut-off and delivery schedule (PDF, 235.24 KB) online.
Other useful information: SAS form required by customer